DSGN
Price
$9.43
Change
+$0.19 (+2.06%)
Updated
Dec 12 closing price
Capitalization
537.17M
93 days until earnings call
Intraday BUY SELL Signals
VTYX
Price
$8.19
Change
-$0.31 (-3.65%)
Updated
Dec 12 closing price
Capitalization
584.43M
95 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DSGN vs VTYX

Header iconDSGN vs VTYX Comparison
Open Charts DSGN vs VTYXBanner chart's image
Design Therapeutics
Price$9.43
Change+$0.19 (+2.06%)
Volume$210.92K
Capitalization537.17M
Ventyx Biosciences
Price$8.19
Change-$0.31 (-3.65%)
Volume$1.85M
Capitalization584.43M
DSGN vs VTYX Comparison Chart in %
DSGN
Daily Signal:
Gain/Loss:
VTYX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DSGN vs. VTYX commentary
Dec 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Hold and VTYX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 14, 2025
Stock price -- (DSGN: $9.24 vs. VTYX: $8.50)
Brand notoriety: DSGN and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 51% vs. VTYX: 17%
Market capitalization -- DSGN: $537.17M vs. VTYX: $584.43M
DSGN [@Biotechnology] is valued at $537.17M. VTYX’s [@Biotechnology] market capitalization is $584.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, VTYX is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 2 TA indicator(s) are bullish while VTYX’s TA Score has 4 bullish TA indicator(s).

  • DSGN’s TA Score: 2 bullish, 6 bearish.
  • VTYX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VTYX is a better buy in the short-term than DSGN.

Price Growth

DSGN (@Biotechnology) experienced а -5.91% price change this week, while VTYX (@Biotechnology) price change was +6.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

DSGN is expected to report earnings on Mar 17, 2026.

VTYX is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTYX($584M) has a higher market cap than DSGN($537M). VTYX YTD gains are higher at: 288.128 vs. DSGN (49.757). DSGN has higher annual earnings (EBITDA): -77.38M vs. VTYX (-115.4M). DSGN has more cash in the bank: 206M vs. VTYX (193M). DSGN has less debt than VTYX: DSGN (1.74M) vs VTYX (10M). DSGN (0) and VTYX (0) have equivalent revenues.
DSGNVTYXDSGN / VTYX
Capitalization537M584M92%
EBITDA-77.38M-115.4M67%
Gain YTD49.757288.12817%
P/E RatioN/AN/A-
Revenue00-
Total Cash206M193M107%
Total Debt1.74M10M17%
TECHNICAL ANALYSIS
Technical Analysis
DSGNVTYX
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
77%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 10 days ago
88%
Bullish Trend 6 days ago
86%
Declines
ODDS (%)
Bearish Trend about 1 month ago
84%
Bearish Trend 11 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signal:
Gain/Loss:
VTYX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACILX32.160.32
+1.01%
American Century Heritage G
GOCAX15.550.13
+0.84%
Gabelli International Small Cap A
FEQNX15.01N/A
N/A
Fidelity Advisor Hedged Equity M
TCPWX14.33-0.01
-0.07%
Transamerica Capital Growth R6
HDSIX23.47-1.31
-5.29%
Hodges Small Cap Growth Institutional

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with IDYA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-1.91%
IDYA - DSGN
53%
Loosely correlated
-0.24%
SYRE - DSGN
49%
Loosely correlated
-0.87%
CRNX - DSGN
49%
Loosely correlated
+2.60%
VRDN - DSGN
48%
Loosely correlated
-0.09%
DYN - DSGN
48%
Loosely correlated
-1.37%
More

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with KYMR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
-2.19%
KYMR - VTYX
40%
Loosely correlated
-2.31%
IPSC - VTYX
39%
Loosely correlated
N/A
REPL - VTYX
38%
Loosely correlated
+0.51%
DSGN - VTYX
36%
Loosely correlated
-1.91%
ROIV - VTYX
36%
Loosely correlated
+5.43%
More